Research progress of EZH2 inhibitor tazemetostat in the treatment of malignant tumor

WANG Lu, REN Yan, YANG Ye, DING Ziwen, LI Zhihui, ZHENG Yan, NI Na

PDF(1540 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1540 KB)
World Clinical Drug ›› 2021, Vol. 42 ›› Issue (06) : 509-513. DOI: 10.13683/j.wph.2021.06.015
Review

Research progress of EZH2 inhibitor tazemetostat in the treatment of malignant tumor

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 42(06): 509-513 https://doi.org/10.13683/j.wph.2021.06.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1540 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉